Targeting human exosomes via bispecific antibody platform

Slide Note
Embed
Share

Explore the potential of targeting human exosomes using a bispecific antibody platform, enhancing drug delivery capabilities. The study delves into engineering exosomes as drug carriers, developing exosome targeting antibodies (ExTAbs), and verifying exosome delivery efficiency. Future directions include cell-specific delivery verification, functional cargo delivery, and exploring new targeting strategies.


Uploaded on Apr 07, 2024 | 4 Views


Targeting human exosomes via bispecific antibody platform

PowerPoint presentation about 'Targeting human exosomes via bispecific antibody platform'. This presentation describes the topic on Explore the potential of targeting human exosomes using a bispecific antibody platform, enhancing drug delivery capabilities. The study delves into engineering exosomes as drug carriers, developing exosome targeting antibodies (ExTAbs), and verifying exosome delivery efficiency. Future directions include cell-specific delivery verification, functional cargo delivery, and exploring new targeting strategies.. Download this presentation absolutely free.

Presentation Transcript


  1. Targeting human exosomes via bispecific antibody platform Kaitlyn Pierpont, Boya Zhang, Sachith Vidanapathirana, Colin Greineder

  2. Exosomes are natures messengers Herrmann, I.K., et al.. Nat. Nanotechnol. (2021).

  3. Engineering exosomes as drug carriers Our Solution Genetic Engineering Chemical Conjugation Requires genetic modification of parental cells May alter exosome structure Requires reproducible chemistry

  4. Exosome Targeting Antibodies (ExTAbs) Anti-CD63 IgG CD63 CD9 CD81 + 2 affinity ligands

  5. ExTAb structure and characterization VH VL IgG 2:1 2:2 Protein Ladder NR R scFv

  6. ExTAb structure and characterization Kd = 4.4 nM Kd = 2.1 nM Kd = 1.1 nM

  7. Exosome purification and decoration CD63-GFP exosomes

  8. Verification of exosome delivery Wildtype ICAM expressing ICAM expressing Cell only Targeted exosomes + wildtype cells Untargeted exosomes + ICAM cells Targeted exosomes + ICAM cells

  9. Verification of exosome delivery cell only Cell only Untargeted exosomes + cells Targeted exosomes + cells Mouse endothelial cells (bEND3)

  10. In vivo specificity for vasculature Untargeted exosome Targeted exosome I 125 I 125

  11. Future Directions Acknowledgements Boya Zhang Verify cell-specific delivery Michaela Dodd Layne Bond Deliver functional cargo Xinye Wang Explore other targets by Jae Bucknor Sachith Vidanapathirana swapping affinity ligands Colin Greineder

  12. Normalize of H5C6 exosome fractions 1.0 I125 counts Untargeted exosome: GFP signal Normalized signal 0.8 I 125 0.6 0.4 0.2 0.0 0 20 fractions 40 Normalize of H5C6/YN1 2;2 exosome fractions 1.0 Targeted exosome: I 125 I125 counts Normalized signal 0.8 GFP signal 0.6 0.4 0.2 0.0 0 20 fractions 40

Related


More Related Content